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PRisk for Cardiovascular Disease
as the Risk for Coronary Heart
isease Changed Among U.S. Adults?
med A. Ajani, MBBS, MPH, Earl S. Ford, MD, MPH
tlanta, Georgia
OBJECTIVES The objective of this study was to compare the 10-year risk of developing coronary heart
disease (CHD) among U.S adults during the years 1988 to 1994 with that among U.S. adults
during the years 1999 to 2002.
BACKGROUND A decline in deaths as the result of CHD has been reported. Data about changes in actual risk
of developing CHD among U.S. adults are sparse.
METHODS Data for noninstitutionalized U.S. residents ages 20 to 79 years who participated in the
National Health and Nutrition Examination Survey (NHANES)-III (1988 to 1994) or
NHANES 1999 to 2002 were examined to compute 10-year risk of developing CHD using
modified Framingham risk score, as adopted by the National Cholesterol Education Program,
Adult Treatment Panel III.
RESULTS Most participants in both surveys had a low (10%) 10-year risk of developing CHD. The
proportion of participants at intermediate (10% to 20%) and high (20%) 10-year risk of
developing CHD also was similar.
CONCLUSIONS Data from national surveys conducted approximately a decade apart showed no appreciable
difference in the distribution of 10-year risk of developing CHD. Greater efforts are needed
to reduce the risk of developing CHD among U.S. adults. (J Am Coll Cardiol 2006;48:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.05.0551177–82) © 2006 by the American College of Cardiology Foundation
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whe mortality from coronary heart disease (CHD) has
eclined during last few decades in the U.S. and elsewhere
1–4). Despite the decline, CHD remains the single largest
iller of American men and women (5). A substantial
ortion of this decline has been attributed to changes in risk
actors for CHD. Efforts are in place to further reduce the
revalence of modifiable CHD risk factors, such as high
lood pressure, high blood cholesterol levels, and smoking.
he prevalence of smoking has been declining (6,7), but the
revalence of high blood pressure has increased in the
nited States (8). However, corresponding data on changes
n overall risk for CHD are sparse.
The Framingham Heart Study published multivariate
odels and a risk equation to estimate 10-year risk of
eveloping CHD (9). The risk score equation, with some
odification, was adopted by the National Cholesterol
ducation Program Expert Panel in their third report on
etection, Evaluation, and Treatment of High Blood Cho-
esterol in Adults (Adult Treatment Panel III; NCEP/
TPIII) (10). The algorithm has been used successfully for
HD risk assessment and formed the basis of clinical
uidelines issued by a European task force on coronary
revention and British recommendations on prevention of
HD (11,12). The distribution of 10-year risk for CHD
From the Division of Adult and Community Health, Center for Chronic Disease
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tlanta, Georgia. This research was conducted at Centers for Disease Control. The
ndings and conclusions in this paper are those of the authors and do not necessarily
epresent the views of the Centers for Disease Control and Prevention.v
Manuscript received September 7, 2005; revised manuscript received May 16, 2006,
ccepted May 23, 2006.mong U.S. adults during the years 1988 to 1994 was
eported previously (13). Since then, however, the preva-
ence of risk factors has changed, and various public health
fforts have been made to reduce the burden of CHD.
herefore, it is important to compute updated distribution
f CHD risk among U.S. adults and determine whether this
istribution has changed. We used data from the National
ealth and Nutrition Examination Survey (NHANES)-III
nd NHANES 1999 to 2002 to calculate modified Fra-
ingham risk score and to compare the prevalence of
0-year risk of CHD among U.S. adults.
ETHODS
he NHANES collects data from a representative sample of
he noninstitutionalized U.S. civilian population using a
tratified multistage sampling design. The NHANES-III
as conducted from 1988 to 1994 (14). A more recent
HANES study started in 1999 and has completed two
-year cycles (1999 to 2000 and 2001 to 2002). For this
tudy, we used combined data for 4 years (15,16). The
urvey received human subject approval from the Centers
or Disease Control and Prevention, all participants pro-
ided informed consent, and data were approved by the
enters for Disease Control and Prevention’s Institutional
eview Board for confidentiality. Participants in NHANES
ere interviewed by trained interviewers at the participants’
ome and were asked to attend an examination center,
here they completed additional questionnaires, underwent
arious examinations, and had blood samples collected.
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CHD Risk Among U.S. Adults September 19, 2006:1177–82To estimate participants’ 10-year risk of developing
HD, we used the modified Framingham algorithm as
dopted by NCEP/ATPIII, thus including participants
ged 20 to 79 years. The modified algorithm included
articipants’ age, gender, systolic blood pressure, current
reatment for high blood pressure, current smoking status,
erum total cholesterol concentrations, and serum high-
ensity lipoprotein cholesterol concentrations. Separate risk
cores were computed for men and women.
Information about participants’ age, gender, smoking
tatus, and current use of medication for high blood pressure
ere collected by interview. Systolic blood pressure mea-
urements were recorded during participants’ visit to the
xamination center. Participants were considered current
mokers if they reported smoking at least 100 cigarettes
uring their life and were currently smoking. Total choles-
erol and high-density lipoprotein cholesterol concentra-
ions were measured by enzymatic assays on a Hitachi 704
nalyzer (Roche Diagnostics, Indianapolis, Indiana).
The NCEP/ATPIII considered patients with existing
HD or CHD equivalents in the group at the highest risk
or CHD (20%), the other two categories being 10-year
HD risk of 10% to 20% and 10%. Stroke and diabetes
ellitus were considered CHD equivalents in these analy-
es. Self-reports of heart attack were used to identify CHD
ases. A history of stroke was identified by self-reports, and
iabetes was identified, as in other studies (4,17), by a
asting blood glucose level 126 mg/dl, nonfasting blood
lucose200 mg/dl, or participants’ self-reported history of
iabetes mellitus.
nalysis. Our analyses were restricted to participants ages
0 to 79 years who attended the examination center (15,331
articipants in NHAHES-III and 8,747 participants in
HANES 1999 to 2002). After excluding participants
hose CHD/CHD-equivalent status could not be deter-
ined, we were left with 15,143 participants in NHANES-
II and 8,726 participants in NHANES 1999 to 2002.
omplete information on all risk factors needed to calculate
modified Framingham risk score was available for 13,888
articipants for NHANES-III and 7,909 participants in
HANES 1999 to 2002. Of the remaining participants
ith some missing information (1,255 in NHANES-III
nd 817 in NHANES 1999 to 2002), we included 818
HANES-III participants and 542 participants in
HANES 1999 to 2000 because their risk group remained
he same using the highest (or worst) possible score for
Abbreviations and Acronyms
CHD  coronary heart disease
NCEP/ATP  National Cholesterol Education
Program/Adult Treatment Panel
NHANES  National Health And Nutrition
Examination Surveyissing components. Therefore, our final study sample Monsisted of 14,706 participants in NHANES-III and 8,451
articipants in NHANES 1999 to 2002.
We categorized the study population from both surveys
nto three levels of 10-year risk for developing CHD: low
10%), intermediate (10% to 20%), and high (20%) and
omputed the proportions of participants at each risk level
eparately for men and women. We also present the results
or three race/ethnicity groups: white, African American,
nd Mexican American. The racial/ethnic composition of
he fourth group (other) was not clear and because a
elatively small number of participants were classified as
other,” estimates for that group were unstable. Therefore,
e did not present separate results for this group. Means
nd proportions were computed separately for each compo-
ent risk factor. We also computed the proportion of
articipants at each risk level after excluding those with a
HD or CHD equivalent to estimate the proportion of the
opulation at high risk because of risk factors only. We used
ampling weights and Software for the Statistical Analysis
f Correlated Data (SUDAAN) (18) to compute population
stimates of CHD risk distribution that accounted for the
omplex sampling design.
ESULTS
ost participants from NHANES-III (76.5%) and
HANES 1999 to 2002 (75.6%) had a 10-year CHD risk
10%. The proportion of participants in the two surveys
ho were at intermediate (11.2% and 11.4%) and high
12.3% and 13.0%) 10-year CHD risk also was similar.
mong men, approximately 15% to 16% of participants in
ach survey had high 10-year risk of CHD (20%) in both
urvey with overlapping confidence intervals. Among
omen, approximately 10% to 11% had high 10-year risk in
he two surveys. Among the 3 racial/ethnic groups, African
mericans had the highest proportion of participants in the
igh-risk group. Although the percentage of white partici-
ants in high 10-year CHD risk group was about the same
n both surveys (approximately 12%), a slightly increased
revalence of high 10-year risk was observed among
frican-American participants in more recent survey
14.4% in NHANES-III and 17.1% in NHANES 1999 to
002) (Table 1).
We also examined the distribution of 10-year CHD risk
mong participants without existing CHD or CHD equiv-
lent conditions (Table 2). Overall, approximately 2% of
articipants without CHD, stroke, or diabetes had a high
0-year risk of developing CHD. The estimates were
imilar for the 2 surveys with overlapping confidence inter-
al. Greater proportion of participants among men had high
0-year risk of CHD (4% and 3.2% in the 2 surveys) than
omen (0.7% and 0.9%), but the estimates across surveys
or men and women were similar. The prevalence of high
0-year risk in the two surveys also was similar among white
2.5% and 2.2%), African-American (2.0% and 1.5%), and
exican-American (1.1% and 1.2%) participants.
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September 19, 2006:1177–82 CHD Risk Among U.S. AdultsThe distribution of individual risk factors included in the
odified Framingham score was examined separately for
en and women (Table 3). Participants in NHANES 1999
o 2002 were slightly older and reported less smoking than
hose in NHANES-III. Total cholesterol and high-density
holesterol concentrations among the participants in the two
urveys were very similar for men, whereas total cholesterol
oncentrations were slightly lower and high-density choles-
erol concentrations were slightly higher among women in
HANES 1999 to 2002. Systolic blood pressure and the
revalence of treatment for high blood pressure were both
reater among participants in NHANES 1999 to 2002 and
he increase in systolic blood pressure was much greater for
omen than for men. The prevalence of myocardial infarc-
ion decreased slightly among both men and women, the
revalence of stroke also increased among both men and
omen, with a slightly greater increase among women, and
he prevalence of diabetes showed much greater increase
mong men (6.4% and 8.5%) but not among women (7.4%
nd 7.2%).
Table 1. Distribution of 10-Year Risk for CH
Overall and by Gender and Race/Ethnicity: N
NHANES III
n <10% 10–20%
Overall 14,706 76.5 11.2
74.8–78.1 10.4–12.1 11
Men 6,820 65.7 19.8
63.5–67.9 18.4–21.2 13
Women 7,886 86.3 3.4
84.6–87.9 2.8–4.1 9
White 5,657 75.4 12.3
73.3–77.5 11.3–13.4 10
Afr. Am. 4,251 77.3 8.3
75.6–78.9 7.3–9.5 13
Mex. Am. 4,184 82.3 6.4
81.0–83.5 5.7–7.2 10
*Data presented as percentage and 95% confidence interval.
Afr. Am.  African American; Mex. Am. Mexican Am
Survey.
Table 2. Distribution of 10-Year Risk for CH
Without CHD or CHD Equivalent: NHANE
NHANES III
n <10% 10–20%
Overall 12,585 85.2 12.5
84.0–86.4 11.6–13.5
Men 5,807 73.8 22.2
71.9–75.7 20.7–23.9
Women 6,778 95.5 3.8
94.6–96.3 3.1–4.6
White 4,859 83.9 13.6
83.3–85.3 12.4–15.0
Afr. Am. 3,630 88.5 9.6
87.0–89.8 8.4–10.9
Mex. Am. 3,550 91.8 7.1
90.9–92.6 6.4–8.0*Data presented as proportion and 95% confidence interval.
CHD  coronary heart disease; other abbreviations as in TableISCUSSION
hese results showed that the overall distribution of 10-year
isk for developing CHD among U.S. adults changed little
etween 1988 to 1994 and 1999 to 2002. During both
eriods, about 1 in every 8 U.S. adults ages 20 to 79 years
ad a 20% 10-year risk of developing CHD. No apparent
hange in 10-year risk of CHD was observed among men
nd women. Although most of the 10-year risk was ex-
lained by presence of prevalent CHD, stroke, and diabetes,
he overall CHD risk distribution among persons without
hese conditions was also similar in the 2 surveys approxi-
ately 10 years apart: in each, approximately 2% of such
ersons were at high risk for CHD and approximately 13%
ere at intermediate risk.
Our results underscore the importance of using an
verall risk assessment, in addition to targeting specific
isk factors. During the last decade or so, important
ublic health efforts have been made to reduce the
revalence of known risk factors for CHD. It is reasonable
ong U.S. Adults Ages 20 to 79 Years,
ES III and NHANES 1999 to 2002
NHANES 1999 to 2002
n <10% 10–20% >20%
8,451 75.6 11.4 13.0
.5 74.1–77.1 10.6–12.2 11.8–14.3
3,932 64.9 19.7 15.5
.1 62.7–67.0 18.3–21.1 13.9–17.2
4,519 85.5 3.8 10.7
.8 83.9–87.0 3.3–4.2 9.5–12.1
3,963 74.9 12.7 12.4
.9 73.0–76.6 11.7–13.8 11.1–13.9
1,662 74.7 8.2 17.1
.8 72.6–76.7 7.4–9.1 15.2–19.2
2,137 83.9 6.1 10.0
.3 81.7–85.9 5.3–7.1 8.3–11.9
; NHANES  National Health and Nutrition Examination
ong U.S. Adults Ages 20 to 79 Years
and NHANES 1999 to 2002
NHANES 1999 to 2002
% n <10% 10–20% >20%
7,166 85.2 12.8 2.0
.7 84.2–86.1 12.0–13.8 1.7–2.3
3,237 74.3 22.5 3.2
.8 72.6–76.0 20.9–24.2 2.7–3.7
3,929 94.9 4.2 0.9
.0 94.2–95.6 3.7–4.7 0.6–1.4
3,462 83.6 14.2 2.2
.1 82.3–84.8 13.1–15.4 1.8–2.7
1,326 88.7 9.7 1.5
.4 87.6–89.8 8.8–10.8 1.0–2.3
1,800 92.0 6.7 1.2
.4 90.8–93.1 5.8–7.8 0.7–2.2D Am
HAN
>20%
12.3
.2–13
14.5
.1–16
10.3
.0–11
12.3
.9–13
14.4
.1–15
11.3
.4–12D Am
S III
>20
2.3
1.9–2
4.0
3.3–4
0.7
0.5–1
2.5
2.0–3
2.0
1.6–2
1.1
0.9–11.
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CHD Risk Among U.S. Adults September 19, 2006:1177–82o expect that the risk of CHD would decrease over time in
onjunction with a reduction in the prevalence of known
HD risk factors. Our results support the findings of
hanges in prevalence of some risk factors, such as decreased
moking over last decade or so. Somewhat surprisingly,
owever, such changes were not reflected in the overall
0-year risk for CHD, which remained essentially un-
hanged during the 10-year period.
One explanation of this finding is that increases in
revalence of some risk factors may have offset the benefits
f decrease in prevalence of other risk factor. The increasing
ge of U.S. population may shift a greater proportion of
.S. adults into the higher risk group. However, our study
as limited to those ages 20 to 79 years, and the change in
verage age of participants over the 2 surveys was 2 years.
ther changes include increase in prevalence of hyperten-
ion as reported previously (8) and reflected by higher
ystolic blood pressure and increased proportion of partici-
ants reporting treatment for hypertension in more recent
urvey. Another risk factor trend resulting in unchanged
0-year CHD risk is the prevalence of diabetes. Consistent
ith an earlier report (19), an increased prevalence of
iabetes was observed in more recent survey. At least part of
his increase may be the result of the increasing prevalence
f obesity (defined as body mass index 30 kg/m2). We
bserved increased prevalence of obesity among men (19.7%
n NHANES-III and 27.3% in NHANES 1999 to 2002)
nd among women (25.0% in NHANES-III and 33.8% in
HANES 1999 to 2002). Similarly, increased prevalence of
bdominal obesity (as used by NCEP/ATP III, waist
ircumference; for men 102 cm, for women 88 cm) was
bserved in more recent survey. The prevalence of abdom-
nal obesity among men increased from 27.5% to 37.4%,
hereas that among women, the increase was from 45.8% to
7.1% in NHANES-III and NHANES 1999 to 2002 data.
hese findings are consistent with increases in prevalence
rom other surveys (20). Although the prevalence of some
armful risk factors has increased over the course of time, a
able 3. Prevalence of Component Risk Factors Used for 10-Yea
ears
NHANES III
Men
n Mean or % SE M
ge 14,706 42.6 0.4
otal cholesterol (mg/dl) 14,242 202.3 1.0
DL cholesterol (mg/dl) 14,151 45.6 0.4
ystolic blood pressure, mg Hg 14,331 122.1 0.5
ypertension treatment, % 14,563 10.1 0.6
urrent smoker, % 14,705 31.9 1.0
HD/CHD equivalent, % 14,706 11.0 0.5
I, % 14,680 4.6 0.4
troke, % 14,703 1.7 0.2
iabetes, % 14,706 6.4 0.3
DL  high-density lipoprotein; MI  myocardial infarction; other abbreviationsecrease in the prevalence of others, such as smoking, has heen reported from national survey (7). This trend also was
bserved in these data. Although the mortality from CHD
as declined in recent years, our finding that the risk of
eveloping CHD has not declined over last decade may be
reason for concern. This may result in a constant burden
r, in a worst-case scenario, increase the community burden
f CHD in the coming years.
Our finding of no significant change in 10-year risk for
eveloping CHD among U.S. adults does not explain
eclining CHD mortality rate. However, previous studies
ave suggested that reduction in case-fatalities, probably
ecause of improved therapeutics, and improved survival of
HD patients may have driven the recent decline in CHD
ortality rates (1,2,21). It is not clear, however, whether the
ecline in CHD mortality is entirely due to case-fatality
eduction because some studies also have reported declining
ncidence (21,22). If reduction in case-fatalities were, in
act, resulting in lower CHD mortality, it can not be ruled
ut in our study by its design and would not be reflected in
0-year risk of developing CHD. Another possible expla-
ation of our finding could be limitations of modified
ramingham scoring, as adopted by National Cholesterol
ducation Program and used in our study. The coronary
rediction algorithm was developed using a middle-aged
hite population sample. The different distribution of
emographic characteristics of U.S. population in recent
ears may have resulted in misclassification of risk scores.
lthough the surveys were conducted a decade apart,
nclusion of people ages 20 to 79 years resulted in a slight
ncrease in average age of participant. Earlier studies have
eported some limitations in using the Framingham risk
core in different socioeconomic groups (23), and some
ocioeconomic disparities in clustering of cardiovascular
isease risk factors also has been reported (24). In our study,
HD risks by socioeconomic status as reflected by level of
ducation (high school or less, more than high school) were
imilar to overall findings. The proportion of people at
igher risk was greater among those with education level of
D Risk Assessment Among Survey Participants Ages 20 to 79
NHANES 1999 to 2002
omen Men Women
or % SE n Mean or % SE Mean or % SE
.7 0.4 8,451 43.9 0.4 44.7 0.3
.2 0.9 8,079 202.4 1.2 203.0 0.9
.3 0.4 8,078 45.8 0.4 56.1 0.5
.8 0.5 8,171 123.1 0.5 120.7 0.5
.2 0.5 8,359 14.2 0.8 17.7 0.9
.7 0.8 8,443 27.4 1.2 21.7 0.9
.6 0.7 8,451 12.7 0.8 9.9 0.6
.2 0.3 8,446 4.3 0.4 1.8 0.3
.6 0.2 8,449 1.9 0.2 2.3 0.3
.4 0.5 8,451 8.5 0.6 7.2 0.4
ables 1 and 2.r CH
W
ean
43
205
55
116
13
25
9
2
1
7igh school or lower in both surveys. However, the results
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September 19, 2006:1177–82 CHD Risk Among U.S. Adultscross surveys were similar (data not shown). Another
ossible explanation can be the level of risk predicted by
ndividual risk factor using the Framingham risk score.
lthough same risk factors are considered at 2 different
oints in time, difference in prevalence of risk factor and
nderlying rates of CHD events may result in need of some
ecalibration, as suggested by an earlier report (25).
Our results reflect some of the possible issues with current
echanisms of health promotion and disease prevention.
uring the last several years, an increasing amount of public
ealth resources and efforts have been directed to reducing
he burden of CHD. Several improvements can be made in
ealth-promotion campaigns. The results of this study
uggest that a more holistic public health approach to
educe CHD risk may be needed. Although targeting
ndividual risk factors to reduce its prevalence is important,
he objective should be to reduce overall risk for disease,
hich will require a more global approach of multifaceted
rograms targeting several risk factors. Health campaigns
argeted toward a single CHD risk factor may not result in
verall reduction in risk, especially if the prevalence of other
HD risk factor or behavior is on the rise. The proportion
f U.S. adults engaged in healthy lifestyle affecting multiple
ehaviors is small (26). Persuading people to adopt a
ultidimensional healthy lifestyle to reduce the 10-year risk
f developing CHD will require serious and concerted
fforts from health care providers and public health profes-
ionals. Appropriate screening for CHD risk, active coun-
eling, and timely treatment by health care providers and
ultifaceted community interventions and motivational
ampaigns by public health professionals will play a major
ole in overall risk reduction. In addition, a truly multidi-
ensional effort focused on primary and secondary preven-
ion and wide variety of activities from reduction in preva-
ence of multiple risk factors to reducing health disparities
y demographic characteristics is likely to require partner-
hip with many outside the traditional health community,
uch as policy makers and media. A call to action for dealing
ith this issue of controlling heart disease in the form of an
ction plan has been developed (27). A successful execution
f such plan and effective implementation of overall risk
educing programs can play major role in reducing public
ealth burden from CHD.
Our findings are based on large study samples from 2
urveys, representative of the U.S. population ages 20 to 79
ears, and thus are applicable to the general U.S. population
ithin this age group. However, because the study was cross
ectional in design and used self-reported data about health
ehaviors; medication use; and diagnoses of CHD, stroke,
nd diabetes, some misclassification cannot be ruled out.
ome participants were excluded from analyses because of
ncomplete data for all components necessary to compute
HD risk. However, on the basis of available characteris-
ics, participants excluded from analyses appeared to be at
reater risk of CHD. Although the reason for exclusion wasncomplete data, such exclusion may have resulted in more
onservative risk estimates.
In summary, our results provide important information
bout recent CHD risk distribution among U.S. adults. We
ound no appreciable change in 10-year risk distribution of
eveloping CHD, although the prevalence of individual risk
actors did change over time. The lack of change in the
0-year risk distribution for CHD among U.S. adults
uggests a need for renewed commitments and more holistic
ublic health efforts at the individual and population level to
educe the overall risk of CHD.
ddress correspondence and reprints requests to: Dr. Umed A.
jani, Centers for Disease Control and Prevention, 4770 Buford
ighway NE, Mailstop K-50, Atlanta, Georgia 30341. E-mail:
ajani@cdc.gov.
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